PT1110943E - Derivados 6-fluorobiciclo¬3.1.0|hexano - Google Patents
Derivados 6-fluorobiciclo¬3.1.0|hexanoInfo
- Publication number
- PT1110943E PT1110943E PT99931532T PT99931532T PT1110943E PT 1110943 E PT1110943 E PT 1110943E PT 99931532 T PT99931532 T PT 99931532T PT 99931532 T PT99931532 T PT 99931532T PT 1110943 E PT1110943 E PT 1110943E
- Authority
- PT
- Portugal
- Prior art keywords
- group
- cycloalkyl
- hydrogen atom
- alkoxy group
- atom
- Prior art date
Links
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 title 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 208000012661 Dyskinesia Diseases 0.000 abstract 1
- 206010019196 Head injury Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 abstract 1
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 abstract 1
- 206010028570 Myelopathy Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000006843 cycloalkyl-C1-5-alkyl Chemical group 0.000 abstract 1
- 125000005366 cycloalkylthio group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 239000003823 glutamate receptor agonist Substances 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000003387 muscular Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000011117 substance-related disease Diseases 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Filling Or Discharging Of Gas Storage Vessels (AREA)
- Fertilizers (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24634398 | 1998-08-31 | ||
| JP8260799 | 1999-03-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1110943E true PT1110943E (pt) | 2004-08-31 |
Family
ID=26423636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99931532T PT1110943E (pt) | 1998-08-31 | 1999-07-26 | Derivados 6-fluorobiciclo¬3.1.0|hexano |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6333428B1 (pt) |
| EP (1) | EP1110943B1 (pt) |
| KR (1) | KR100469182B1 (pt) |
| CN (1) | CN1247527C (pt) |
| AT (1) | ATE269293T1 (pt) |
| AU (1) | AU746806B2 (pt) |
| CA (1) | CA2341865C (pt) |
| DE (1) | DE69918136T2 (pt) |
| DK (1) | DK1110943T3 (pt) |
| ES (1) | ES2222715T3 (pt) |
| PT (1) | PT1110943E (pt) |
| WO (1) | WO2000012464A1 (pt) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6313159B1 (en) | 1999-08-20 | 2001-11-06 | Guilford Pharmaceuticals Inc. | Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors |
| AU6785501A (en) * | 2000-06-28 | 2002-01-08 | Taisho Pharmaceutical Co Ltd | Intermediate and process for producing fluorinated carboxylic acid derivative from the same |
| EP1295865A4 (en) * | 2000-06-28 | 2005-06-01 | Taisho Pharmaceutical Co Ltd | NEW DICARBOXYLENE DERIVATIVES |
| EP1423411A2 (en) * | 2001-07-09 | 2004-06-02 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| EP1463713A1 (en) * | 2001-11-23 | 2004-10-06 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| WO2003057661A1 (en) * | 2001-12-21 | 2003-07-17 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| KR20090031962A (ko) * | 2001-12-27 | 2009-03-30 | 다이쇼 세이야꾸 가부시끼가이샤 | 6-플루오로비시클로[3.1.0]헥산 유도체 |
| DE60325968D1 (de) * | 2002-06-11 | 2009-03-12 | Lilly Co Eli | Prodrugs von exzitatorischen aminosäuren |
| AU2003242924A1 (en) * | 2002-07-05 | 2004-01-23 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| US7960579B2 (en) | 2003-06-26 | 2011-06-14 | Taisho Pharmaceutical Co., Ltd. | 2-amino-bicyclo [3.1.0] hexane-2,6-dicarboxylic ester derivative |
| RU2409557C2 (ru) * | 2003-06-26 | 2011-01-20 | Таишо Фармасьютикал Ко., Лтд. | Сложноэфирное производное 2-амино-бицикло[3.1.0]гексан-2,6-дикарбоновой кислоты |
| US7786314B2 (en) * | 2003-11-07 | 2010-08-31 | Taisho Pharmaceutical Co., Ltd | Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto |
| US20070043100A1 (en) | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
| AU2006282896A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| WO2007047978A2 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| JP2009513672A (ja) | 2005-10-31 | 2009-04-02 | ブレインセルス，インコーポレイティド | 神経発生のｇａｂａ受容体媒介調節 |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
| US20080045725A1 (en) | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
| MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US7998971B2 (en) * | 2006-09-08 | 2011-08-16 | Braincells Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| TW200845978A (en) * | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| US8722894B2 (en) * | 2007-09-14 | 2014-05-13 | Janssen Pharmaceuticals, Inc. | 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones |
| SI2203439T1 (sl) | 2007-09-14 | 2011-05-31 | Ortho Mcneil Janssen Pharm | 1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni |
| NZ584152A (en) | 2007-09-14 | 2011-11-25 | Ortho Mcneil Janssen Pharm | 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| RU2492170C9 (ru) * | 2007-11-14 | 2013-12-27 | Орто-Макнейл-Янссен Фармасьютикалз, Инк. | Имидазо[1,2-а]пиридиновые производные и их применение в качестве положительных аллостерических модуляторов рецепторов mglur2 |
| WO2009142184A1 (ja) | 2008-05-21 | 2009-11-26 | 大正製薬株式会社 | 酵素を用いたビシクロ［３．１．０］ヘキサン誘導体の製造方法 |
| AU2009289784B2 (en) | 2008-09-02 | 2012-03-22 | Addex Pharma S.A. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
| US8697689B2 (en) | 2008-10-16 | 2014-04-15 | Janssen Pharmaceuticals, Inc. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| WO2010060589A1 (en) | 2008-11-28 | 2010-06-03 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| WO2010111080A2 (en) | 2009-03-27 | 2010-09-30 | Eli Lilly And Company | Optimized treatment of schizophrenia |
| CN102439008B (zh) | 2009-05-12 | 2015-04-29 | 杨森制药有限公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途 |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| BRPI1010831A2 (pt) | 2009-05-12 | 2016-04-05 | Addex Pharmaceuticals Sa | derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2 |
| JP5852665B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
| PT2649069E (pt) | 2010-11-08 | 2015-11-20 | Janssen Pharmaceuticals Inc | Derivados de 1,2,4-triazolo[4,3-a]piridina e sua utilização como moduladores alostéricos positivos de recetores mglur2 |
| WO2012062759A1 (en) | 2010-11-08 | 2012-05-18 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| US9296710B2 (en) | 2011-06-17 | 2016-03-29 | Eli Lilly And Company | Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mGlu2 receptor agonist |
| AR089718A1 (es) * | 2012-02-01 | 2014-09-10 | Lilly Co Eli | AGONISTAS DE mGlu2/3 |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| AU2015208233B2 (en) | 2014-01-21 | 2019-08-29 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
| ES2860298T3 (es) | 2014-01-21 | 2021-10-04 | Janssen Pharmaceutica Nv | Combinaciones que comprenden moduladores alostéricos positivos del receptor glutamatérgico metabotrópico de subtipo 2 y su uso |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL182285B1 (pl) | 1994-08-12 | 2001-12-31 | Lilly Co Eli | Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL |
| US5661184A (en) | 1994-08-12 | 1997-08-26 | Eli Lilly And Company | Psychiatric agents |
| IL118727A (en) * | 1995-06-29 | 2003-01-12 | Lilly Co Eli | (-)-2-spiro-5-hydantoinbicyclo [3.1.0] hexane-6-carboxylic acid, salts thereof and use thereof for the preparation of (+)-(2) aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid |
| US5912248A (en) * | 1995-11-16 | 1999-06-15 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| GB9605429D0 (en) | 1995-11-16 | 1996-05-15 | Lilly Co Eli | Excitatory amino acid receptor antagonists |
| JP2000500752A (ja) | 1995-11-16 | 2000-01-25 | イーライ・リリー・アンド・カンパニー | 興奮性アミノ酸受容体アンタゴニスト |
| ZA969485B (en) | 1995-11-16 | 1998-05-12 | Lilly Co Eli | Excitatory amino acid receptor antagonists. |
| ZA983930B (en) * | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
| JP3727791B2 (ja) | 1998-01-08 | 2005-12-14 | ファイザー・プロダクツ・インク | 二環式［３．１．０］ヘキサン及び関連化合物 |
| JP4171549B2 (ja) * | 1998-01-28 | 2008-10-22 | 大正製薬株式会社 | 含フッ素アミノ酸誘導体 |
| DK1052246T3 (da) | 1998-01-28 | 2003-06-16 | Taisho Pharmaceutical Co Ltd | Fluorholdige aminosyrederivater |
-
1999
- 1999-07-26 CN CNB998101834A patent/CN1247527C/zh not_active Expired - Fee Related
- 1999-07-26 PT PT99931532T patent/PT1110943E/pt unknown
- 1999-07-26 AT AT99931532T patent/ATE269293T1/de active
- 1999-07-26 DE DE69918136T patent/DE69918136T2/de not_active Expired - Lifetime
- 1999-07-26 DK DK99931532T patent/DK1110943T3/da active
- 1999-07-26 KR KR10-2001-7002530A patent/KR100469182B1/ko not_active Expired - Fee Related
- 1999-07-26 ES ES99931532T patent/ES2222715T3/es not_active Expired - Lifetime
- 1999-07-26 WO PCT/JP1999/003984 patent/WO2000012464A1/ja not_active Ceased
- 1999-07-26 AU AU48007/99A patent/AU746806B2/en not_active Ceased
- 1999-07-26 CA CA002341865A patent/CA2341865C/en not_active Expired - Fee Related
- 1999-07-26 US US09/763,408 patent/US6333428B1/en not_active Expired - Lifetime
- 1999-07-26 EP EP99931532A patent/EP1110943B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010092268A (ko) | 2001-10-24 |
| DE69918136D1 (de) | 2004-07-22 |
| HK1049996A1 (en) | 2003-06-06 |
| EP1110943B1 (en) | 2004-06-16 |
| CA2341865C (en) | 2006-01-17 |
| AU4800799A (en) | 2000-03-21 |
| CA2341865A1 (en) | 2000-03-09 |
| WO2000012464A1 (en) | 2000-03-09 |
| CN1247527C (zh) | 2006-03-29 |
| KR100469182B1 (ko) | 2005-02-02 |
| AU746806B2 (en) | 2002-05-02 |
| EP1110943A1 (en) | 2001-06-27 |
| CN1383423A (zh) | 2002-12-04 |
| ES2222715T3 (es) | 2005-02-01 |
| ATE269293T1 (de) | 2004-07-15 |
| DE69918136T2 (de) | 2005-07-07 |
| US6333428B1 (en) | 2001-12-25 |
| DK1110943T3 (da) | 2004-10-11 |
| EP1110943A4 (en) | 2002-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1110943E (pt) | Derivados 6-fluorobiciclo¬3.1.0|hexano | |
| ATE236118T1 (de) | Fluorhaltige aminosäurederivate | |
| WO2003051315A3 (en) | Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 | |
| TW200634016A (en) | Novel thieno-pyridine and thieno-pyrimidine derivatives and their use as positive allosteric modulators of mglur2-receptors | |
| AU2003212882A1 (en) | 2 - piperazine - pyridines useful for treating pain | |
| SG155938A1 (en) | Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors | |
| CA2469813A1 (en) | Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 | |
| EP1099692A4 (en) | N, N-SUBSTITUTED CYCLIC AMINE DERIVATIVES | |
| EP1408042A4 (en) | NEW ISOXAZOLOPYRIDONE DERIVATIVES AND THEIR USE | |
| KR20030017562A (ko) | 신규 디카르복실산 유도체 | |
| NZ590951A (en) | Cyclic nucleotide phosphodiesterases PDE10 inhibitors for treating neurological disorders | |
| BG106228A (en) | Substituted imidazothiazoles as antidepressant agents | |
| AU6517598A (en) | 4-tetrahydropyridylpyrimidine derivative | |
| EP1637517A4 (en) | 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative | |
| JP2009526844A5 (pt) | ||
| EP1153922A4 (en) | HETERODIAZINONE DERIVATIVES | |
| MXPA04005838A (es) | Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su prepacion y las composiciones farmaceuticas que los contienen. | |
| BR0110874A (pt) | Derivados de sulfonamida | |
| ATE361072T1 (de) | N-acetyl-l-pipecolic säure als promoter der produktion des neurotrophischen faktors | |
| AU696458B2 (en) | Optically active, substituted phenylalkylamine derivatives | |
| HUT58339A (en) | Process for producing new organosilane derivatives and pharmaceutical compositions containing them | |
| DOP2004000983A (es) | Antagonistas 4-cicloalquilaminopirazol pirimidina de nmda/nr2b |